What is he best known for?
The fields of study he is best known for:
James D. Marks mostly deals with Antibody, Molecular biology, Antigen, Phage display and Monoclonal antibody.
James D. Marks has included themes like Polypeptide chain, Nucleic acid, Endocytosis and Virology in his Antibody study.
The various areas that James D. Marks examines in his Molecular biology study include Mutant, Affinity maturation, Immunoglobulin light chain, Internalization and In vivo.
His studies deal with areas such as Receptor–ligand kinetics, In vitro and Genomic library as well as Antigen.
His Phage display research includes elements of Red blood cell and Hybridoma technology.
His Monoclonal antibody study combines topics from a wide range of disciplines, such as Immunohistochemistry and Epidermal growth factor.
His most cited work include:
- Methods for producing members of specific binding pairs (2702 citations)
- By-passing immunization: Human antibodies from V-gene libraries displayed on phage (2472 citations)
- Production of anti-self antibodies from antibody segment repertoires and displayed on phage (1356 citations)
What are the main themes of his work throughout his whole career to date?
James D. Marks spends much of his time researching Antibody, Molecular biology, Monoclonal antibody, Antigen and Virology.
James D. Marks works in the field of Antibody, focusing on Epitope in particular.
The study incorporates disciplines such as In vitro, Affinity maturation, Immunoglobulin light chain, Phage display and In vivo in addition to Molecular biology.
His work carried out in the field of Phage display brings together such families of science as Peptide library and Fusion protein.
His Monoclonal antibody research incorporates elements of Cancer research and Neutralization.
His Antigen research includes themes of Cell surface receptor and Cell culture.
He most often published in these fields:
- Antibody (53.58%)
- Molecular biology (37.25%)
- Monoclonal antibody (22.35%)
What were the highlights of his more recent work (between 2011-2021)?
- Antibody (53.58%)
- Monoclonal antibody (22.35%)
- Molecular biology (37.25%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Antibody, Monoclonal antibody, Molecular biology, Cancer research and Epitope.
His study of Phage display is a part of Antibody.
James D. Marks has researched Monoclonal antibody in several fields, including Recombinant DNA, Virology, Neutralization, Botulism and Antitoxin.
His study looks at the relationship between Molecular biology and topics such as In vivo, which overlap with Cancer cell.
His Cancer research research is multidisciplinary, incorporating perspectives in Cell, Ephrin, Cancer, Immunology and Erythropoietin-producing hepatocellular receptor.
As a part of the same scientific family, James D. Marks mostly works in the field of Epitope, focusing on Single-Chain Antibodies and, on occasion, Endopeptidase.
Between 2011 and 2021, his most popular works were:
- Selective Targeting of TGF-β Activation to Treat Fibroinflammatory Airway Disease (68 citations)
- N-Terminal labeling of filamentous phage to create cancer marker imaging agents. (54 citations)
- Single-chain antibody based immunotoxins targeting Her2/neu. Design optimization and impact of affinity on antitumor efficacy and off-target toxicity (51 citations)
In his most recent research, the most cited papers focused on:
His main research concerns Antibody, Molecular biology, Epitope, Monoclonal antibody and In vivo.
The Antibody study combines topics in areas such as Cancer research, Tumor microenvironment, Clostridium botulinum, Cancer immunotherapy and Botulism.
His studies in Molecular biology integrate themes in fields like Biodistribution, Carcinogenesis, Toxin, Antigen and Microarray.
As part of one scientific family, James D. Marks deals mainly with the area of Epitope, narrowing it down to issues related to the Biochemistry, and often Ethylene glycol.
His Monoclonal antibody research integrates issues from Antitoxin and Virology.
His In vivo study combines topics in areas such as Immunoliposome, Pharmacokinetics, Liposome, Phage display and Drug.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
